Cereolysin
Need Assistance?
  • US & Canada:
    +
  • UK: +

Cereolysin

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Cerebrolysin is a multimodal neuropeptide drug used for the treatment of ischemic and hemorrhagic stroke, brain trauma, dementia and cognitive impairment. It can improve the brain's self-repair ability by stimulating nerve recovery.

Category
Peptide APIs
Catalog number
BAT-009061
CAS number
72270-31-6
Molecular Formula
C59H94N16O19S
Molecular Weight
1363.54
Synonyms
HE383245
Sequence
CERE{Pyl}LYSIN
Storage
Store at -20°C
2. A Bacillus cereus cytolytic determinant, cereolysin AB, which comprises the phospholipase C and sphingomyelinase genes: nucleotide sequence and genetic linkage
M S Gilmore, A L Cruz-Rodz, M Leimeister-Wächter, J Kreft, W Goebel J Bacteriol. 1989 Feb;171(2):744-53. doi: 10.1128/jb.171.2.744-753.1989.
A cloned cytolytic determinant from the genome of Bacillus cereus GP-4 has been characterized at the molecular level. Nucleotide sequence determination revealed the presence of two open reading frames. Both open reading frames were found by deletion and complementation analysis to be necessary for expression of the hemolytic phenotype by Bacillus subtilis and Escherichia coli hosts. The 5' open reading frame was found to be nearly identical to a recently reported phospholipase C gene derived from a mutant B. cereus strain which overexpresses the respective protein, and it conferred a lecithinase-positive phenotype to the B. subtilis host. The 3' open reading frame encoded a sphingomyelinase. The two tandemly encoded activities, phospholipase C and sphingomyelinase, constitute a biologically functional cytolytic determinant of B. cereus termed cereolysin AB.
Online Inquiry
Verification code
Inquiry Basket